#1 IQAir Dealer - FREE Shipping - NO Tax - Order Online or Call 845.827.6091 Now!
IQAir Air Purifiers
IQAir Cleanroom H13
|
The IQAir Cleanroom H13 has been designed specifically for the removal of airborne particles. The systems feature the highest air delivery and longest filter life of any IQAir particle filter system. To allow for maximum air delivery the systems contain no gas phase filtration.
Applications
- Microbiological control in hospitals
- Clean production areas - Clean research areas - Pharmaceutical laboratories
|
|
All systems come complete with filters, owners manual, set of 4 casters (except GCX series and Cleanroom H13), 6 foot power cord, hand-signed certificate of guaranteed performance, user guide video (both VHS and DVD) and remote control with batteries (except compact model).
| Specifications | Other Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1. User Control Panel 2. Carrying Handle 3. No-Draft Diffuser 4. Cleanroom-Grade HyperHEPA Filter 5. Snap-Open Locking Arms 6. High-Performance Centrifugal Fan 7. Advanced Fan Control 8. Pre-Max Pre-Filter (Class F9) 9. Dual Floor Air Intake
|
Professional Control Of Airborne Particulates
Larger HyperHEPA filter The Cleanroom offers a larger HyperHEPA filter (ca. 4.1 m2, instead of 3.7 m2). Also the unit has a larger pre-filter (ca. 4.1 m2, instead of 2.3 m2), therefore more capacity and longer life. This feature is particularly useful when the systems are in 24-hour non-stop use.
Higher efficiency HyperHEPA filter
Individually tested and certified HyperHEPA replacement filters
Anti-microbially treated HyperHEPA
Anti-microbially treated pre-filter
Higher air flow rate
Anti-Tampering Features
Positive and Negative Pressure Environments
The creation of positive pressure helps to protect clean areas from contaminants entering from adjacent rooms (e.g. protective isolation of immuno-compromised patients, controlled environments for medical device manufacturing).
Decentralised Airborne Infection Control in Health-Care Facilities
Hospital-acquired aspergillosis for example has been recognised increasingly as a cause of severe illness and high mortality in immunocompromised individuals, e.g. patients undergoing chemotherapy and/or organ or bone marrow transplants. In the light of the marked increase in nosocomial infections over recent years, many of which are caused by drug-resistant pathogens, the importance of using high-efficiency air filtration systems beyond the confines of so-called "critical areas" (such as operation theatres) has once again been emphasised. Both the World Health Organisation (WHO) and the Centers for Disease Control and Prevention (CDC), advise that, wherever possible, preventive infection control measures should be implemented to reduce the risk of nosocomial infections. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||



